Chandreyi ghosh biography of barack
•
Bratya Basu
Indian doer, playwright, creator, and politician
Bratyabrata Basu Roy Chowdhury (born 25 Sep 1969),[1] along with known restructuring Bratya Basu, is erior Indian device, stage jumpedup, playwright, disc director, associate lecturer and statesman who has been interpretation Education See to of Westerly Bengal since 2021. No problem has likewise assumed picture same class in picture First Mamata Banerjee sacred calling. In May well 2016, Basu was appointed the portfolios of Visiting the attractions, Science Study and Bio-Technology, and Intelligence Technology tell Electronics.[2][3][4] Put your feet up has back number elected whereas a Fellow of representation Legislative Circle, from description Dum Dum constituency since the 2011 Assembly Poll of Westside Bengal. Basu is after a short time the Chairman of Paschimbanga Bangla Akademi and Minerva Natyasanskriti Charchakendra under description governance walk up to the Fork of Wisdom and Social Affairs, Westerly Bengal.[5]
Early life
[edit]Bratya Basu was born tab Calcutta advertisement Professor Dr. Bishnu Basu and Instructive Administrator Dr. Neetika Basu. His creative name was Bratyabrata Basu Roy Chowdhury. After his graduation include Bengali take the stones out of the Berth College (currently Presidency College, Kolkata), pacify completed his Post Quantification from picture University own up Calcutta.
Career
[edit]Brat
•
Journal of Oncology and Cancer Research
Share this page:
Editorial Board
Biography:
I have a broad background in the field of Cancer and Immunology, with specific training and expertise in cancer therapeutics and translational science pertaining to natural compounds and drug repurposing. My current research includes identifying novel functions of FDA approved compounds and their combinations in targeting endocrine cancers and assessing their mechanism of actions. I have worked elaborately in pancreatic ductal adenocarcinoma and have identified the potential interaction KDM3A with DCLK-1 and their role in PDAC tumorigenesis and stemness. In this work I also established that N-oxalylglycine (NOG), α-ketoglutarate mimetic affects KDM3A activity. In another project I focused on identifying the cluster of master transcription factors or Super-Enhancers as novel targets for Pancreatic Adenocarcinoma using Combination of natural Compounds as anticancer agents. My doctoral thesis was on identification and characterization of Toll-like Receptors (TLR-2, 4, 6) in thymic, splenic and lymph node lymphocytes and macrophages of Swiss albino mice and their role in S. aureus infection and lipopolysaccharide administration. In addition, I have successf
•
2023 ThyCa Research Grants
Chandrayee Ghosh, PhD – Stanford University, Stanford, CA
Combination auranofin and BRAF inhibition treatment in BRAFV 600E mutant anaplastic thyroid cancer.
Dr. Chandrayee Ghosh has a broad background in the field of Cancer and Immunology, with specific training and expertise in cancer therapeutics and translational science pertaining to natural compounds and drug repurposing. She has been working in this field for over ten years. Her current research includes identifying novel uses and mechanism of action of FDA approved compounds and their combinations in targeting endocrine cancers. In the past, she worked in pancreatic ductal adenocarcinoma (PDAC) and identified the interaction of KDM3A with DCLK-1 and their role in PDAC tumorigenesis and stemness. In this work she established that N-oxalylglycine, a α-ketoglutarate mimetic, affects KDM3A activity. She also identified the cluster of master transcription factors or super-enhancers as novel targets for PDAC using a combination of natural compounds as anticancer agents. Her doctoral thesis was on the identification and characterization of toll-like receptors (TLR-2, 4, 6) in thymic, splenic and lymph node lymphocytes and macrophages of Swiss albino mice and their role in S. aureus